MASON R PRESTON has a total of 18 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals are LEGARDA IBANEZ JUAN JOSE, NEOPHARM and JIANGSU KANGYUAN PHARMACEUTICA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Czechia | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Iceland | 1 | |
#9 | Mexico | 1 | |
#10 | Peru | 1 | |
#11 | Poland | 1 | |
#12 | Slovakia | 1 | |
#13 | Tunisia | 1 | |
#14 | United States | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mason R Preston | 17 |
Publication | Filing date | Title |
---|---|---|
BRPI0517802A | Synergistic effect of amlodipine and atorvastatin on nitric oxide release by aortic endothelial cells | |
ZA200108685B | Synergistic effects of amlodipine and atorvastatin. | |
US7129265B2 | Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy | |
AU8308501A | Synergistic effect of amlodipine and atorvastatin | |
EA004435B1 | Synergistic effects of amlodipine and atorvastatin |